29.05.20 ijBio index
Infojet ClubijBio: Farm Involved ijBio-Index:
29 May 2020:
AstraZeneca (AZN) $54,5 (+2%)
Inovio (INO) $14,7 (+10.5%)
Moderna (MRNA) $61,5 (+10.7%)
Abbot (ABT) $94,9 (+3%)
Gilead (GILD). $77,8 (+3.33%)
Adaptive (ADPT) $38,7 (-0.6%)
CytoDyn (CYDY) $3 (+5%)
AbbVie (ABBV) $92,7 (+2,9%)
Deciphera (DCPH) $58,6 (+2.75%)
Sorrento (SRNE) $5 (+2%)
At close 29.05.20= 501,4 (+3,8%)
previous day <---> next day
At close 28.05.20=483 (+0,83)
At close 27.05.20= 479 (-1,1%)
At close 26.05.20= 485 (-3,8%)
Index was launched 26.05.20 = 504
--
Pfizer stock plunges 7% after breast cancer study halted
AstraZeneca Scored A 'Home Run' With Its Cancer Drug — And Shares Popped
Alan Fournier Adds 4 Stocks to Portfolio
Coronavirus update: Trump quits WHO in multi-front battle vs. China; NYC eyes June 8 reopen
Here's Why Arcus Biosciences Stock Gained as Much as 15.9% Today
Raging BullHow He Made $2.8M Trading Stocks Part-Time At Home
Why virus stocks are driving market volatility
Exclusive: Sanofi stops enrolling COVID-19 patients in hydroxychloroquine trials
AstraZeneca's Blockbuster Lung Cancer Drug Has a Huge Sales Boost Ahead
Moderna Vaccine Unlikely to Revive U.S. Economy, Survey Says
AstraZeneca Reports Progress With Lung Cancer Drug
Glaxo Plans to Make 1B Doses of Coronavirus Vaccine Adjuvant
Pharma Stock Roundup: MRK, RHHBY Give Coronavirus Updates,SNY to Sell Stake in REGN
AstraZeneca Stock Jumps on Strong Cancer Drug Data
Is Johnson & Johnson Stock A Buy As Pressure Mounts For A Coronavirus Vaccine?
The Dow Is Edging Down. Salesforce.com Falls as AstraZeneca Rises.
European agency panel recommends approval of J&J's Ebola vaccine
European, South Korean authorities vie for COVID-19 antiviral remdesivir
Is Abbott Stock A Buy After Defending The Accuracy Of Coronavirus Test?
4 Stocks to Watch as Dow Breezes Past 25,000 Points
Pakistan drug firm to import potential COVID-19 treatment from Bangladesh
CFRX: Four Abstracts Published in 30th ECCMID Abstract Book; Financing Overhang Removed as Pfizer Makes Second Investment…l
Is Abbott Stock A Buy After Defending The Accuracy Of Coronavirus Test?
MacKeeperHow much junk can your Mac hide?
Here’s why Citi says stocks have rallied — and why new fuel for gains is now needed
Pakistan drug firm to import potential COVID-19 treatment from Bangladesh
AstraZeneca Unveils Data Behind New Win For Blockbuster Drug
S.Korea seeks to import anti-viral remdesivir as new virus cases emerge
Raging BullHow He Made $2.8M Trading Stocks Part-Time At Home
Is GlaxoSmithKline plc's (LON:GSK) High P/E Ratio A Problem For Investors?
U.S. FDA asks 5 firms to recall diabetes drug with high levels of probable carcinogen
GlaxoSmithKline (GSK) Gains As Market Dips: What You Should Know
Texas Infections Jump 3.2%, U.S. Cases Increase: Virus Update
Why it may take the travel industry a few years to get back to normal
With M&A Hit, Wall Street Bankers Keep Busy With Stock Sales
GlaxoSmithKline Plans to Produce 1 Billion Doses of Its Pandemic Vaccine Adjuvant in 2021
---- 28.05.2020
Merck, Pfizer share gains contribute to Dow's 86-point climb
France Paves Way to Reopen; English Soccer in June: Virus Update
Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine
Moderna Stock Is Giving Investors a Wild Ride. Blame It on Shifting Covid-19 Vaccine News.
Ad Raging BullHow He Made $2.8M Trading Stocks Part-Time At Home
Dow up 200 points on gains in shares of Boeing, Pfizer
How Novavax is pulling out all the stops to produce a coronavirus vaccine by next year
Gilead study shows shorter 5-day course of remdesivir works as well as 10-day one
YouTube Virus Misinformation Fight Trips on Drug Touted by Trump
ER doctor: 12-18 month coronavirus vaccine timeline 'is extremely optimistic'
Pfizer (PFE) Down 1.9% Since Last Earnings Report: Can It Rebound?
TradeZero America Co-founder on investor trends during market volatility
AstraZeneca says it may consider exposing vaccine trial participants to virus
Pfizer ties up with glass maker Corning for vial supply
Gilead Inks 10-Year Deal With Arcus for Immuno-oncology Drugs
Roche and Gilead Sciences Testing Two-Drug Covid-19 Combo
Gilead Is Creating A Coronavirus Drug Stockpile — Is Gilead Stock A Buy?
Dow climbs 69 points on gains in shares of Boeing, Merck
Ironwood to Halt MD-7246 Development After Study Failure
Don't Waste Your Money on Penny Stocks; These 3 Are Better Buys
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?
Is ISRG Stock A Buy After Coronavirus Slammed Quarterly Growth?
Roche's shares rise on news of study testing Actemra, remdesivir in COVID-19 patients
A $39B Stock Fund Puts Dividends in Perspective During the Coronavirus Crisis
Is Johnson and Johnson Stock a Buy?
Coronavirus 2020: Where to Invest $500 Right Now
GSK targets production of 1bn doses of coronavirus vaccine booster
GSK aims for 1 billion doses with COVID vaccine booster plan
Moderna extends lipids deal to boost COVID-19 vaccine candidate output
With M&A Dead, Wall Street Bankers Keep Busy With Stock Sales
The lessons and consequences of a failed megadeal
U.S. FDA finds high levels of carcinogen in diabetes drug metformin
Top 1st-Quarter Buys of Steven Cohen's Firm
Abbott (ABT) Gains But Lags Market: What You Should Know
Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know
Gilead’s Remdesivir May Be a Coronavirus Silver Bullet — But It’s Already Baked in the Stock Price
Why Moderna Stock Dropped Today
Covid Report: Why Moderna's Vaccine Prodded A Mass Biotech Sell-Off